Evaluation of Pharmaceutical Companies Introduced in Tehran Stock Exchange Using Balanced Scorecard Method and Data Envelopment Analysis
Background: Pharmaceutical science is one of the most dynamic scientific fields in the production of new science and technology due to its tremendous impact on improving health. Techniques such as DEA (data envelopment analysis) and BSC (balanced scorecard) are tools that cannot be considered alt...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2025-02-01
|
| Series: | Journal of Pharmacoeconomics and Pharmaceutical Management |
| Subjects: | |
| Online Access: | https://jppm.tums.ac.ir/index.php/jppm/article/view/235 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850217062888112128 |
|---|---|
| author | Fatemeh Sadat Aghaei Majid Annabi |
| author_facet | Fatemeh Sadat Aghaei Majid Annabi |
| author_sort | Fatemeh Sadat Aghaei |
| collection | DOAJ |
| description |
Background: Pharmaceutical science is one of the most dynamic scientific fields in the production of new science and technology due to its tremendous impact on improving health. Techniques such as DEA (data envelopment analysis) and BSC (balanced scorecard) are tools that cannot be considered alternative techniques. The main purpose of this study is to evaluate the efficiency of pharmaceutical companies introduced in the Tehran Stock Exchange based on the model Balanced Scorecard, and using data envelopment analysis.
Methods: In the beginning, performance evaluation indicators from four perspectives: financial, customer, internal processes, and learning and growth; then the efficiency of these companies is considered based on the indicators considered in the model (BSC), measured using (DEA). The statistical population of this study consisted of 13 pharmaceutical companies operating in Iran and listed on the Tehran Stock Exchange. After collecting data, the efficiency rating of pharmaceutical companies was calculated using the output-driven CCR model. This model has been implemented using DEA-Solver software.
Results: The results of the model implementation include efficiency scores for each decision unit. As a result, companies that have a rating of 1 are effective. Others are considered ineffective. The results show that out of the 13 pharmaceutical companies surveyed, 9 companies are effective and the rest are ineffective.
Conclusion: As a result, companies that have a score of 1 are efficient and compared to other units, they have relatively better used their resources and obtained better results.
|
| format | Article |
| id | doaj-art-869cec87c94b4a6d938c919404283f43 |
| institution | OA Journals |
| issn | 2383-4498 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | Journal of Pharmacoeconomics and Pharmaceutical Management |
| spelling | doaj-art-869cec87c94b4a6d938c919404283f432025-08-20T02:08:09ZengTehran University of Medical SciencesJournal of Pharmacoeconomics and Pharmaceutical Management2383-44982025-02-01103Evaluation of Pharmaceutical Companies Introduced in Tehran Stock Exchange Using Balanced Scorecard Method and Data Envelopment AnalysisFatemeh Sadat Aghaei0Majid AnnabiDepartment of Pharmacoeconomics, Faulty of Pharmacy, Tehran Medical Sciences, Islamic Azad university, Tehran, Iran Background: Pharmaceutical science is one of the most dynamic scientific fields in the production of new science and technology due to its tremendous impact on improving health. Techniques such as DEA (data envelopment analysis) and BSC (balanced scorecard) are tools that cannot be considered alternative techniques. The main purpose of this study is to evaluate the efficiency of pharmaceutical companies introduced in the Tehran Stock Exchange based on the model Balanced Scorecard, and using data envelopment analysis. Methods: In the beginning, performance evaluation indicators from four perspectives: financial, customer, internal processes, and learning and growth; then the efficiency of these companies is considered based on the indicators considered in the model (BSC), measured using (DEA). The statistical population of this study consisted of 13 pharmaceutical companies operating in Iran and listed on the Tehran Stock Exchange. After collecting data, the efficiency rating of pharmaceutical companies was calculated using the output-driven CCR model. This model has been implemented using DEA-Solver software. Results: The results of the model implementation include efficiency scores for each decision unit. As a result, companies that have a rating of 1 are effective. Others are considered ineffective. The results show that out of the 13 pharmaceutical companies surveyed, 9 companies are effective and the rest are ineffective. Conclusion: As a result, companies that have a score of 1 are efficient and compared to other units, they have relatively better used their resources and obtained better results. https://jppm.tums.ac.ir/index.php/jppm/article/view/235Pharmaceutical scienceBalanced Scorecard (BSC)Data Envelopment Analysis (DEA)Efficiency evaluationTehran Stock ExchangePerformance evaluation |
| spellingShingle | Fatemeh Sadat Aghaei Majid Annabi Evaluation of Pharmaceutical Companies Introduced in Tehran Stock Exchange Using Balanced Scorecard Method and Data Envelopment Analysis Journal of Pharmacoeconomics and Pharmaceutical Management Pharmaceutical science Balanced Scorecard (BSC) Data Envelopment Analysis (DEA) Efficiency evaluation Tehran Stock Exchange Performance evaluation |
| title | Evaluation of Pharmaceutical Companies Introduced in Tehran Stock Exchange Using Balanced Scorecard Method and Data Envelopment Analysis |
| title_full | Evaluation of Pharmaceutical Companies Introduced in Tehran Stock Exchange Using Balanced Scorecard Method and Data Envelopment Analysis |
| title_fullStr | Evaluation of Pharmaceutical Companies Introduced in Tehran Stock Exchange Using Balanced Scorecard Method and Data Envelopment Analysis |
| title_full_unstemmed | Evaluation of Pharmaceutical Companies Introduced in Tehran Stock Exchange Using Balanced Scorecard Method and Data Envelopment Analysis |
| title_short | Evaluation of Pharmaceutical Companies Introduced in Tehran Stock Exchange Using Balanced Scorecard Method and Data Envelopment Analysis |
| title_sort | evaluation of pharmaceutical companies introduced in tehran stock exchange using balanced scorecard method and data envelopment analysis |
| topic | Pharmaceutical science Balanced Scorecard (BSC) Data Envelopment Analysis (DEA) Efficiency evaluation Tehran Stock Exchange Performance evaluation |
| url | https://jppm.tums.ac.ir/index.php/jppm/article/view/235 |
| work_keys_str_mv | AT fatemehsadataghaei evaluationofpharmaceuticalcompaniesintroducedintehranstockexchangeusingbalancedscorecardmethodanddataenvelopmentanalysis AT majidannabi evaluationofpharmaceuticalcompaniesintroducedintehranstockexchangeusingbalancedscorecardmethodanddataenvelopmentanalysis |